Table 1 Baseline clinicopathological characteristics in patients with breast cancer.
From: Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
Variables | At admission (n = 134) |
|---|---|
Age, years | 41.90 ± 4.43 |
Tumor diameter, cm | 3.80 ± 1.54 |
Axillary lymphadenopathy, n (%) | 46 (34.2) |
Histological type, n (%) | |
DCIS | 23 (17.1) |
IDC | 90 (67.1) |
ILC | 21 (15.7) |
TNM stage, n (%) | |
II | 100 (74.3) |
III | 29 (21.4) |
IV | 6 (4.3) |
BMI, Kg/m2 | 32.9 ± 3.3 |
Blood pressure, mmHg | |
Systolic | 122.1 ± 7.6 |
Diastolic | 77.8 ± 8.2 |
Renal function tests | |
Creatinine, mg/dL | 11.5 ± 3.9 |
Liver function tests | 0.74 ± 0.2 |
AST, U/L | 20.8 ± 4.3 |
ALT, U/L | 27.05 ± 3.1 |
ALP, U/L | 62.8 ± 4.9 |
